SHAREHOLDER ALERT: WeissLaw LLP Reminds CLGX, VGAC, SNCA, And RNET Shareholders About Its Ongoing Investigations

NEW YORK, March 11, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.
Author:
Publish date:

NEW YORK, March 11, 2021 /PRNewswire/ --

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16 th Floor New York, NY  10036 (212) 682-3025 (888) 593-4771 stockinfo@weisslawllp.com

CoreLogic, Inc. (CLGX) - Get Report

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CoreLogic, Inc. (CLGX) - Get Report in connection with the proposed acquisition of the company by funds managed by Stone Point Capital and Insight Partners.  Under the terms of the agreement, CLGX shareholders will receive $80.00 in cash for each share of CLGX common stock that they own.  If you own CLGX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/clgx/

VG Acquisition Corp. (VGAC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of VG Acquisition Corp. (VGAC) in connection with the company's proposed merger with 23andMe, Inc. ("23andMe").  Under the terms of the merger agreement, VGAC will acquire 23andMe through a reverse merger that will result in 23andMe becoming a public company traded on the NYSE.  If you own VGAC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/vgac/

Seneca Biopharma, Inc. (SNCA) - Get Report

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Seneca Biopharma, Inc. (SNCA) - Get Report in connection with the company's proposed merger with Leading BioSciences, Inc. ("LBS").  Under the terms of the agreement, LBS shareholders will receive shares of SNCA, resulting in LBS stockholders owning a majority of the combined company, with SNCA shareholders owning just 26.2% of the surviving combined entity.  If you own SNCA shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslawllp.com/snca/

RigNet, Inc. (RNET) - Get Report

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of  RigNet, Inc. (RNET) - Get Report in connection with RNET's proposed merger with Viasat, Inc. ("Viasat").  Under the terms of the agreement, RNET shareholders will receive 0.1845 shares of Viasat stock per RNET share they hold, representing implied per-share merger consideration of approximately $9.91 based upon Viasat's March 10, 2021 closing stock price of $53.71.  If you own RNET shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/RNET/  

View original content to download multimedia: http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-clgx-vgac-snca-and-rnet-shareholders-about-its-ongoing-investigations-301245920.html

SOURCE WeissLaw LLP